The Division of Pediatric Rheumatology is actively involved in clinical research activities.
- The Childhood Arthritis and Rheumatology Research Alliance (CARRA) is the main national pediatric rheumatology research group which allows for collaborative research on a national level.
As part of CARRA we are involved in:
- The national registry where we collect data on disease and treatment for children with rheumatic diseases (juvenile idiopathic arthritis, juvenile dermatomyositis, systemic lupus erythematosus, scleroderma, and others)
- Several prospective observational outcomes of different treatment strategies for juvenile arthritis and other rheumatic diseases
- Pharmaceutical studies
Our division is a site for national and international pharmaceutical trials using novel medications for the treatment of pediatric rheumatologic conditions with the goal of obtaining FDA approval for the use of these medications in the pediatric population.
Current and past companies we have worked with include Pfizer, Roche, Sobi, and Genentech.
We have two full-time research coordinators assigned to our division who provide research support.
More information on pediatric clinical research can be found at the Center for Excellence in Child and Adolescent Health Research.